Jump to navigation
About us
Business
Investor
Society
Media
People
Search form
Search
En
Bg
Pl
Ru
About us
The manufacturing of medicinal products is for us not only a matter of implementing a certain technological process, but a human mission based on high standards of quality, safety and efficacy of medications
Our purpose
What we do
Our heritage
Responsible business
Ethical code of conduct
Sopharma and the Pharma Industry
Pharma industry trends
Risk factors
Management
Corporate Governance
Corporate Governance system
Corporate Governance Program
Contacts & Locations
What we do
What we do
Developing, manufacturing and delivering accessible treatment to millions of people
Our Heritage
Our heritage
Contributing to the history of healthcare in Bulgaria
Business
Sopharma Group is an integrated business focused in the health care sector including three main business lines:
Manufacturing of pharmaceutical products
Non – pharma activities
Distribution of health related products
Manufacturing of pharmaceutical products
Pharmaceutical products
Pharmaceutical development
Licensing & manufacturing
Marketing Authorisations
Drug safety
Quality management
Post-authorisation activities
Non-pharma activities
Distribution of health related products
Distribution in Bulgaria
Distribution abroad
Sopharma as a partner
Contract manufacturing
Packaging services
Products development
Batch control
Manufacturing and facilities
Sopharma as a partner
Sopharma as a partner
We have almost one century of tradition and a modern approach to production
The distribution system
Our distribution model
A modern tale of innovation
Investor
Nurturing our sense of responsibility towards financial stakeholders by long lasting solid results
Equity story
Looking ahead
Financial Highlights
Investor news
Share & Shareholders
Privacy Notice
Stock performance
Analyst coverage
Notifications under Art. 19 of Regulation (EU) No 596/2014
Dividends
Warrants Prospectus
General Meetings of Shareholders
General meeting of warrant holders
Financial reports
Auditors
Presentations
Services
IR Kit
Events
Email Notification
IR FAQ
IR Contacts
Equity story
Equity story
85+ years track record in the pharma industry
Looking ahead
Looking ahead
Becoming a strong regional player and the first partnering choice
Society
Proud to provide society with solutions having a direct consequence on everyday life and improving the quality of life of millions of people
Our stakeholders
Healthy means Happy
Accessible medicines
Sustainable innovation
Reporting
Our stakeholders
Our Stakeholders
The company runs its social responsibility program to improve lives and to ensure sustainable development of the society
Healthy means Happy
Healthy means Happy
Sopharma AD supports the idea that health is not a lifestyle issue, but the only up to date and conscious way of living
Media
We have an active and crucial role in raising standards of everyday life, in making people more informed, healthier, happier and safer
News
Events
Stories
Pharma library
Media gallery
Awards & Recognitions
Media kit
The road to digital AGM
The road to “digital” AGM
The globalization is a challenge in every aspect of our life
The big IR challenge
The big IR challenge
Creating a clear message and making a long story short
People
At Sopharma you can shape your own path by working with people that improve health standards day by day
What drives us at work
People first
Values Ambassador
Meet our professionals
Career paths
R&D
Quality management
Corporate functions
Production
Students and graduates
How to join us
People: our most valuable investment
People: our most valuable investment
It is important to feel part of a community
Quality is a habit
Quality is a habit
The quality in clinical trials is a moving target
Home
>
Documents
>
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 5 June 2023.
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 5 June 2023.
Date:
6 June 2023
Share
Podziel się
Сподели
Поделиться
Add to folder
Page folder
Print
Latest update:
Tuesday, June 6, 2023 - 12:05
‹
›
×
About us
Our purpose
Shareholders
Articles of association
What we do
Our heritage
Responsible business
Ethical code of conduct
Sopharma and the Pharma Industry
Pharma industry trends
Risk factors
Management
Corporate Governance
Corporate Governance system
Corporate Governance Program
Contacts & Locations
Business
Manufacturing of pharmaceutical products
Pharmaceutical products
Pharmaceutical development
Licensing & manufacturing
Marketing Authorisations
Drug safety
Quality management
Post-authorisation activities
Non-pharma activities
Distribution of health related products
Distribution in Bulgaria
Distribution abroad
Sopharma as a partner
Contract manufacturing
Packaging services
Products development
Batch control
Manufacturing and facilities
Investor
Equity story
Looking ahead
Financial Highlights
Investor news
Share & Shareholders
Privacy Notice
Stock performance
Analyst coverage
Notifications under Art. 19 of Regulation (EU) No 596/2014
Dividends
Warrants Prospectus
General Meetings of Shareholders
General meeting of warrant holders
Financial reports
Auditors
Presentations
Services
IR Kit
Events
Email Notification
IR FAQ
IR Contacts
Society
Our stakeholders
Healthy means Happy
Accessible medicines
Sustainable innovation
Reporting
Media
News
Events
Stories
Pharma library
Media gallery
Awards & Recognitions
Media kit
People
What drives us at work
People first
Values Ambassador
Meet our professionals
Career paths
R&D
Quality management
Corporate functions
Production
Students and graduates
How to join us
Софарма представи различен поглед към фармацията на Базара на професиите
Special Pages links menu
What we do
Our Heritage
Looking ahead